Astroglial type-1 cannabinoid (CB 1 ) receptors are involved in synaptic transmission, plasticity and behavior by interfering with the so-called tripartite synapse formed by pre-and post-synaptic neuronal elements and surrounding astrocyte processes. However, little is known concerning the subcellular distribution of astroglial CB 1 receptors. In particular, brain CB 1 receptors are mostly localized at cells plasmalemma, but recent evidence indicates their functional presence in mitochondrial membranes. Whether CB 1 receptors are present in astroglial mitochondria has remained unknown. To investigate this issue, we included conditional knock-out mice lacking astroglial CB 1 receptor expression specifically in glial fibrillary acidic protein (GFAP)-containing astrocytes (GFAP-CB 1 -KO mice) and also generated genetic rescue mice to re-express CB 1 receptors exclusively in astrocytes (GFAP-CB 1 -RS). To better identify astroglial structures by immunoelectron microscopy, global CB 1 knock-out (CB 1 -KO) mice and wild-type (CB 1 -WT) littermates were intra-hippocampally injected with an adeno-associated virus expressing humanized renilla green fluorescent protein (hrGFP) under the control of human GFAP promoter to generate GFAPhrGFP-CB 1 -KO and -WT mice, respectively. Furthermore, double immunogold (for CB 1 ) and immunoperoxidase (for GFAP or hrGFP) revealed that CB 1 receptors are present in astroglial mitochondria from different hippocampal regions of CB 1 -WT, GFAP-CB 1 -RS and GFAPhrGFP-CB 1 -WT mice. Only non-specific gold particles were detected in mouse hippocampi lacking CB 1 receptors. Altogether, we demonstrated the existence of a precise molecular architecture of the CB 1 receptor in astrocytes that will have to be taken into account in evaluating the functional activity of cannabinergic signaling at the tripartite synapse.
.
The activation of CB 1 receptors in astrocytes promotes astroglial differentiation (Aguado et al., 2006) and mediates neuron-astrocyte communication that plays a role in synaptic plasticity, memory and behavior G omez-Gonzalo et al., 2015; Han et al., 2012; Metna-Laurent & Marsicano, 2015; Navarrete & Araque, 2008 , 2010 Navarrete, Diez, & Araque, 2014 ; Oliveira da Cruz, Robin, Drago, Marsicano, & Metna-Laurent, 2015) . Furthermore, CB 1 receptor activation is involved in energy supply to the brain through the control of leptin receptor expression in astrocytes (Bosier et al., 2013) .
The CB 1 receptor-mediated astrocyte functions are highly dependent on the CB 1 receptor distribution in astrocytes relative to close neuronal compartments, particularly at synapses (Bonilla-Del Río et al., 2017) . However, the low CB 1 receptor expression in astrocytes (Bosier et al., 2013; Han et al., 2012; Kov acs et al., 2017; Rodriguez, Mackie, & Pickel, 2001 ) and mitochondria (B enard et al., 2012; Hebert-Chatelain et al., 2014a; 2016) constrains a consolidated picture of the subcellular CB 1 receptor distribution in the astroglial compartments that holds the anatomical substrate for a functional interaction with the nearby synapses under normal or pathological conditions (Bonilla-Del Río et al., 2017 ). Yet, whether intracellular CB 1 receptors exist in astroglial mitochondria has remained unknown. In the hippocampus, mitochondrial CB 1 (mtCB 1 ) receptor activation affects synaptic transmission and memory formation through reduced phosphorylation of specific subunits of the complex I electron transport system, and through decreased mitochondrial respiration and mobility (Hebert-Chatelain et al., 2016) .
These effects are due to intra-mitochondrial Gai protein activation by mtCB 1 receptors that leads to the inhibition of soluble adenylyl cyclase and, consequently, to the decrease in intra-mitochondrial protein kinase A (PKA) activity (Hebert-Chatelain et al., 2016) . New tools based on genetic rescue strategies have proven to be useful to dissect the sufficiency of the CB 1 receptors expressed in specific cell types for a particular brain function (de Salas-Quiroga et al., 2015; Guti errez-Rodríguez et al., 2017; Lange et al., 2017; Remmers et al., 2017; Ruehle et al., 2013; Soria-G omez et al., 2014) . Importantly, knock-in mice with cell type-specific rescue of CB 1 receptors in dorsal telencephalic glutamatergic neurons (Glu-CB 1 -RS) or GABAergic neurons (GABA-CB 1 -RS)
showed that the distribution pattern and the subcellular CB 1 receptor localization is maintained as it is observed in the wild-type hippocampus (Guti errez-Rodríguez et al., 2017; Remmers et al., 2017) .
In this study, we hypothesized that intracellular CB 1 receptors are present in astroglial mitochondria as observed in neuronal and muscular mitochondria. The GFAP-CB 1 -RS rescue mice expressing the CB 1 receptor gene exclusively in the astrocytes and the GFAPhrGFP-CB 1 -WT mice are ideal genetic tools to test this hypothesis. Our results show that the subcellular CB 1 receptor distribution in astrocytes in the rescue mice completely matches the endogenous CB 1 receptor expression and localization in astrocytes of the wild-type mouse hippocampus. Moreover, our findings illustrate for the first time the localization of CB 1 receptors in astroglial mitochondria. Maximal efforts were made in order to minimize the number and the suffering of the animals used.
| M A TER I A LS
2.1.2 | Conventional and conditional CB 1 -KO CB 1 -KO mice were generated and genotyped as previously described (Marsicano et al., 2002) . In addition, conditional CB 1 receptor mutant mice were obtained by crossing the respective Cre expressing mouse line with CB 1 f/f mice (Marsicano et al., 2003) , using a three-step breeding protocol (Monory et al., 2006) . Specifically, transgenic mice expressing the inducible version of the Cre recombinase CreERT2 under the control of the human glial fibrillary acid protein promoter, i.e. GFAPCreERT2 mice (Hirrlinger, Scheller, Braun, Hirrlinger, & Kirchhoff, 2006) were crossed with mice carrying CB 1 receptor "floxed" sequence (Marsicano et al., 2003) . As a result, transgenic mice CB 1 f/f;GFAP-CreERT2 were obtained (Han et al., 2012) .
2.1.3 | Generation of GFAP-CB 1 -RS STOP-CB 1 mice were previously generated by inserting a loxP-flanked stop cassette into the 5 0 UTR of the coding exon of the CB 1 gene, 32 nucleotides upstream of the translational start codon . The STOP-CB 1 mice were crossed with GFAP-CreERT2 mice (Hirrlinger, Scheller, Braun, Hirrlinger, & Kirchhoff, 2006 ) to obtain CB 1 stop/stop;GFAP-CreERT2 mice.
Seven to nine-week-old CB 1 f/f;GFAP-CreERT2 and CB 1 f/f littermates, as well as CB 1 stop/stop;GFAP-CreERT2 and CB 1 stop/stop littermates were treated daily for eight consecutive days with 1 mg/kg (i.p.) of either tamoxifen or 4OH-tamoxifen synthesized as previously reported (Detsi, Koufaki, & Calogeropoulou, 2002; Yu & Forman, 2003) to induce the Cre-dependent astroglial deletion of CB 1 (GFAP-CB 1 -KO and GFAP-CB 1 -WT littermate mice) or its exclusive astroglial re-expression (rescue, GFAP-CB 1 -RS and STOP-CB 1 littermates). Mice were used for immunocytochemistry 3-5 weeks after the last day of tamoxifen or 4OH-tamoxifen injections.
2.1.4 | Generation of GFAPhrGFP-CB 1 -WT and GFAPhrGFP-CB 1 -KO mice
Intrahippocampal injection of a recombinant adeno associated virus expressing hrGFP under the control of the human GFAP promoter (von Jonquieres et al., 2013) were performed in CB 1 -WT and CB 1 -KO mice to generate GFAPhrGFP-CB 1 -WT and GFAPhrGFP-CB 1 -KO, respectively. The vector backbone was the pAAV-GFAP-hChR2(H134R)-EYFP kindly provided by Karl Deisseroth (Stanford University, CA, USA). We replaced the hChR2(H134R)-EYFP with the cDNA encoding for hrGFP by using standard molecular cloning techniques. The virus production and purification, as well as the injection procedure were performed as previously described (Chiarlone et al., 2014) . Coordinates for intrahippocampal injections were: anteroposterior -2.0 mm, mediolateral 6 1.5 mm, dorsoventral -2 mm relative to bregma. Mice were allowed to recover for at least 4 weeks after surgery before their anatomical characterization. was applied before statistical tests and subsequently data were analyzed using nonparametric tests (Mann-Whitney U test when k 5 2 or Kruskal-Wallis test when k > 2). Potential variability between animals of the same mutant mouse line was assessed statistically. Because no differences were detected, all data within each mouse line were pooled.
| Tissue isolation
2.1.8 | Semi-quantification of the distance from the CB 1 receptor particles in astroglial mitochondria to the nearest synapse Image-J software was used to measure the distance between the CB 1 receptor immunogold particles on the astrocytic mitochondria and the nearest synapse on single 60 nm-thick sections. Data were tabulated, analyzed and displayed as mean 6 SEM using GraphPad Prism 5 software.
| RE S U L TS
3.1 | Subcellular CB 1 receptor localization in the mutant mice
Astrocytes and their processes were identified by DAB immunodeposits of GFAP or hrGFP and the CB 1 receptor was detected by immunogold labeling. As expected, the CB 1 receptor was mainly localized on neuronal terminals, preterminal membranes and, to a lesser extent, on GFAP-labeled astrocytes. CB 1 receptor-immunopositive synaptic terminals followed in serial ultrathin sections obtained from the CA1 ( Figure   1 ) and dentate molecular layer ( 3.2 | CB 1 receptor assessment in astrocytes of the CA1 stratum radiatum
The percentage of the CB 1 receptor immunopositive astrocytic processes in the CA1 stratum radiatum of the GFAP-CB 1 -RS (37.12% 6 3.79%) was not statistically different (p > .05; Figure 5a ) relative to the CB 1 -WT mouse (42.06% 6 3.56%), however the proportion in the GFAPhrGFP-CB 1 -WT was significantly higher (59.91% 6 3.29%; ***p < .001; Figure 5a ). Only background metal particles were found in CA1 astrocytes of the STOP-CB 1 , GFAP-CB 1 -KO, CB 1 -KO and GFAPhrGFP-CB 1 -KO mice (***p < .001; Figure 5a ).
The density of CB 1 receptor immunoparticles on astrocytic membranes (particles/mm) was also analyzed (Figure 5b ). Similar densities were detected in the GFAP-CB 1 -RS (.128 6 .020) and the CB 1 -WT (.135 6 .019; p > .05; Figure 5b ) however the density was much higher in the GFAPhrGFP-CB 1 -WT (.384 6 .039; ***p < .001; Figure 5b ). Only residual non-specific particles were observed in the STOP-CB 1 (.005 6
.003), GFAP-CB 1 -KO (.005 6 .003), CB 1 -KO (.001 6 .001) and
GFAPhrGFP-CB 1 -KO mice (.004 6 .002; ***p < .001; Figure 5b ).
5.31% 6 .84% of the total CB 1 receptor labeling in the CB 1 -WT, 11.97% 6 2.17% in the GFAPhrGFP-CB 1 -WT (p > .05; Figure 5c ) and 95.31% 6 1.87% in the GFAP-CB 1 -RS were in astrocytic processes (***p < .001; Figure 5c ). Only background immunoparticles were detected in astrocytic processes of the STOP-CB 1 , GFAP-CB 1 -KO, CB 1 -KO and GFAPhrGFP-CB 1 -KO (***p < .001; Figure 5c ). As a comparison, 65.52% 6 2.44% of the total CB 1 receptor gold particles in the CB 1 -WT, 75.13% 6 4.06% in the GFAP-CB 1 -KO and 56.32% 6 2.73% in the GFAPhrGFP-CB 1 -WT were distributed on synaptic terminals (p > .05; Figure 5d ). Scattered metal particles were found in GFAP-CB 1 -RS, STOP-CB 1 , CB 1 -KO and GFAPhrGFP-CB 1 -KO mice (***p < .001; Figure 5d ).
3.3 | CB 1 receptor assessment in astrocytes of the dentate molecular layer
The proportion of the CB 1 receptor immunopositive astrocytic processes in the GFAP-CB 1 -RS (39.84% 6 3.50%) and the CB 1 -WT (44.67% 6 3.85%) was statistically similar (p > .05; Figure 6a ), but it was significantly higher in the GFAPhrGFP-CB 1 -WT group (59.99% 6 3.37%; **p < .01; Figure 6a ). Particles were virtually undetectable in the STOP-CB 1 , GFAP-CB 1 -KO, CB 1 -KO and GFAPhrGFP-CB 1 -KO mice (***p < .001; Figure 6a ).
The CB 1 receptor density (particles/mm) on astrocytic membranes did not differ statistically between the GFAP-CB 1 -RS (.138 6 .016) and the CB 1 -WT (.112 6 .011; p > .05; Figure 6b ) but it was higher in the GFAPhrGFP-CB 1 -WT group (.334 6 .033; ***p < .001; Figure 6b ). Negligible particle numbers were noticed in the STOP-CB 1 (.006 6 .003),
GFAP-CB 1 -KO (.006 6 .003), CB 1 -KO (.004 6 .002) and GFAPhrGFP-CB 1 -KO (.002 6 .002; ***p < .001; Figure 6b ).
Of the total CB 1 receptor labeling, 5.35% 6 1.00% in the CB 1 -WT, 13.13% 6 2.60% in the GFAPhrGFP-CB 1 -WT (P > .05; Figure 6c ) and 95.61% 6 1.56% in the GFAP-CB 1 -RS was in astrocytes (***P < .001; Figure 6c ). Non-specific CB 1 receptor immunoparticles were found on FIG URE 1 Follow up of a CB 1 receptor positive astrocytic process in the CA1 stratum radiatum of CB 1 -WT. Double pre-embedding immunogold (CB 1 receptor) and immunoperoxidase (GFAP) method for electron microscopy. Serial ultrathin sections showing a GFAP positive (DAB immunodeposits) astrocytic process (as) with a few CB 1 receptor immunoparticles on the astrocytic membrane throughout the reconstruction (b-f). In the astrocyte, CB 1 receptor labeling is also observed on the mitochondrial membrane (d). A CB 1 receptor-positive terminal (ter) is closely associated to the astrocytic process. Black thin arrows: neuronal CB 1 receptor labeling; black thick arrows: astrocytic CB 1 receptor labeling; white arrow: mitochondrial CB 1 receptor labeling in astrocyte; as: astrocytic process; ter: axon terminal; m: CB 1 receptorpositive mitochondria in astrocyte. Scale bar: 0.5 mm astrocytic processes in the STOP-CB 1 , GFAP-CB 1 -KO, CB 1 -KO and GFAPhrGFP-CB 1 -KO mice (***P < .001; Figure 6c ). Conversely, 64.27% 6 2.88% of the total CB 1 receptor labeling in the CB 1 -WT, 76.17% 6 4.70% in the GFAP-CB 1 -KO and 57.17% 6 2.19% in the GFAPhrGFP-CB 1 -WT was located on synaptic terminals (P > .05; Figure 6d) . Residual metal particles were detected in the GFAP-CB 1 -RS, STOP-CB 1 , CB 1 -KO and GFAPhrGFP-CB 1 -KO (***P < .001; Figure 6d ).
| CB 1 receptor localization in astroglial mitochondria
CB 1 receptor labeling was observed in mitochondria (mtCB 1 receptors) of astrocytes distributed throughout the CA1 stratum radiatum ( Figures   1d and 3a,c,g ) and dentate molecular layer (Figures 2a,f and 4a,c,f,g ). In
CB 1 -WT mice, 11.12% 6 1.80% of the astrocytic mitochondrial sections in the CA1 stratum radiatum and 11.56% 6 2.33% in the dentate molecular layer were CB 1 receptor immunopositive (Figures 7a,b) . The percentage was roughly similar in GFAP-CB 1 -RS (CA1 stratum radiatum: 12.39% 6 1.81% (p > .05; Figure 7a ); dentate molecular layer:
11.48% 6 1.76% (p > .05; Figure 7b ) and GFAPhrGFP-CB 1 -WT (CA1 stratum radiatum: 13.12% 6 2.53% (P > .05; Figure 7a ); dentate molecular layer: 13.74% 6 3.20% (p > .05; Figure 7b ). Non-specific mitochondrial particles were detected in STOP-CB 1 (CA1 stratum radiatum: 4.66% 6 1.55%, **p < .01; Figure 7a ; dentate molecular layer:
5.38% 6 1.22%, *p < .05; Figure 7b ), GFAP-CB 1 -KO (CA1 stratum radiatum: 3.97% 6 1.70%, **p < .01; Figure 7a ; dentate molecular layer:
3.04% 6 1.04%, **p < .01; Figure 7b ), CB 1 -KO (CA1 stratum radiatum:
2.97% 6 1.15%. ***p < .001; Figure 7a ; dentate molecular layer:
2.49% 6 .80%, ***p < .001; Figure 7b ) and GFAPhrGFP-CB 1 -KO mice (CA1 stratum radiatum: .95% 6 .95%, ***p < .001; Figure 7a ; dentate molecular layer: 1.98% 6 .91%, ***p < .001; Figure 7b ).
3.5 | Distance from the astroglial mtCB 1 receptors to the nearest synapse
The distance between the astrocytic mtCB 1 receptor particles and the midpoint of the nearest synapse was assessed in CB 1 -WT, GFAP-CB 1 -RS and GFAPhrGFP-CB 1 -WT hippocampi (Figure 8 ; table 1). In the CA1, 10.55% 6 4.01% of the total synapses analyzed were in a range of 0-400 nm from the astrocytic mtCB 1 receptor particles in CB 1 -WT, 2.67% 6 2.67% in GFAP-CB 1 -RS and 7.41% 6 3.70% in GFAPhrGFP-CB 1 -WT. 38.54% 6 8.32% of the synapses were located between 400 and 800 nm in CB 1-WT, 49.28% 6 2.87% in GFAP-CB 1 -RS and 51.85% 6 3.70% in GFAPhrGFP-CB 1 -WT. 29.51% 6 6.85% of the synapses were detected between 800 and 1,200 nm in CB 1 -WT, 37.26% 6 2.02% in GFAP-CB 1 -RS and 29.63% 6 7.41% in GFAPhrGFP-CB 1 -WT. Finally, 21.40% 6 5.56% of the synapses were found at more than 1,200 nm from the astrocytic mtCB 1 receptor in CB 1 -WT, 10.79% 6 2.94% in GFAP-CB 1 -RS and 14.81% 6 7.41% in GFAPhrGFP-CB 1 -WT (Figure 8 ; Table 1 ). In the dentate molecular layer, 11.11% 6 6.42% of the total synapses analyzed were at 0-400 nm in CB 1 -WT, 2.82% 6 1.48% in GFAP-CB 1 -RS and 1.52% 6
1.52% in GFAPhrGFP-CB 1 -WT. 50% 6 3.21% of the synapses were located at a distance of between 400 and 800 nm from the astrocytic mtCB 1 immunoparticle in CB 1 -WT, 47.57% 6 4.81% in GFAP-CB 1 -RS and 57.37% 6 6.26% in GFAPhrGFP-CB 1 -WT. 23.15% 6 .93% of them were located between 800 and 1,200 nm in CB 1 -WT, 43.79% 6 3.13%
in GFAP-CB 1 -RS and 35.86% 6 2.53% in GFAPhrGFP-CB 1 -WT. Finally, 18.52% 6 3.70% of the synapses in CB 1 -WT, 11.82% 6 3.51% in GFAP-CB 1 -RS and 5.25% 6 2.72% in GFAPhrGFP-CB 1 -WT were observed at more than 1,200 nm from the astrocytic mtCB 1 receptor particles ( Figure 8 ; Table 1 ).
FIG URE 3 CB 1 receptor localization in identified astrocytes and astrocytic mitochondria in the CA1 stratum radiatum of mutant mice. Preembedding immunogold and immunoperoxidase method for electron microscopy. In CB 1 -WT (a), CB 1 receptor immunoparticles are localized on membranes of astrocytic processes. Mitochondrial CB 1 receptor labeling is also visualized in identified astrocytes of CB 1 -WT (a). As expected, CB 1 receptor immunoparticles are also on membranes of synaptic terminals and preterminals (a). No CB 1 receptor immunolabeling is detected in CB 1 -KO (b), confirming the specificity of the CB 1 receptor antibody. Astrocytic processes, but not axon terminals, are CB 1 receptor immunopositive in GFAP-CB 1 -RS (c). Note in this mutant, CB 1 receptor labeling on the outer membrane of an astrocytic mitochondrion (c). CB 1 receptor particles are found in synaptic terminals and neuronal mitochondria, but not in astrocytes and astrocytic mitochondria, of GFAP-CB 1 -KO (d). No CB 1 receptor immunoparticles are observed in STOP-CB 1 (e). In GFAPhrGFP-CB 1 -WT (f and g), presynaptic terminals and astrocytic processes are CB 1 receptor positive. Mitochondrial CB 1 receptor labeling is also visualized in identified astrocytes (g). No CB 1 receptor immunolabeling is detected in GFAPhrGFP-CB 1 -KO (h). Black arrowheads: excitatory synapses; white arrowheads: inhibitory synapses; black thin arrows: neuronal CB 1 receptor immunoparticles; black thick arrows: astrocytic CB 1 receptor immunoparticles; white thick arrows: mitochondrial CB 1 receptor labeling in astrocytes; white thin arrows: mitochondrial CB 1 receptor labeling in neurons; as: astrocytic processes; ter: terminal; den: dendrite; sp: dendritic spine; m: CB 1 receptor-positive astroglial/neuronal mitochondria. Scale bars: 0.5 mm Pre-embedding immunogold and immunoperoxidase method for electron microscopy. In CB 1 -WT, CB 1 receptor immunoparticles are localized on membranes of presynaptic terminals, astrocytic processes as well as on mitochondrial membranes of identified astrocytes (a). Importantly, the CB 1 receptor labeling is absent in CB 1 -KO (b). In GFAP-CB 1 -RS, CB 1 receptor gold particles are only detected on astrocytes and astrocytic mitochondria but not on neuronal synaptic compartments (c). Conversely, CB 1 receptor immunolabeling is only present on synaptic boutons and not on astrocytes of GFAP-CB 1 -KO (d). The CB 1 receptor labeling is not observed in the STOP-CB 1 mouse (e). In GFAPhrGFP-CB 1 -WT, CB 1 receptor immunoparticles are localized on membranes of presynaptic terminals, astrocytic processes and astrocytic mitochondria (f and g). No CB 1 receptor immunolabeling is detected in GFAPhrGFP-CB 1 -KO (h). Black arrowheads: excitatory synapses; white arrowheads: inhibitory synapses; black thin arrows: neuronal CB 1 receptor immunoparticles; black thick arrows: astrocytic CB 1 receptor immunoparticles; white arrows: mitochondrial CB 1 receptor labeling in astrocytes; as: astrocytic processes; ter: terminal; den: dendrite; sp: dendritic spine; m: CB 1 receptor-positive astrocytic mitochondria. Scale bars: 0.5 mm first step, we determined the CB 1 receptor expression and distribution in the conditional mutant mice in order to draw the level of agreement with the CB 1 receptor expression pattern in the CB 1 -WT mice. The combined pre-embedding immunogold and immunoperoxidase method applied in this study has been previously proven to be an excellent approach for the localization of the CB 1 receptor in astrocytes (BonillaDel Río et al., 2017; Bosier et al., 2013; Han et al., 2012) and mitochondria (B enard et al., 2012; Hebert-Chatelain et al., 2014a ,b, 2016 . Specificity control experiments of the CB 1 receptor antibodies were carried out in CB 1 -KO and STOP-CB 1 mice (carrying a loxP-flanked stop cassette inserted into the sequences of the 5'UTR of the CB 1 receptor).
According to recent observations, we detected very low levels of metal particle deposits in STOP-CB 1 (Remmers et al., 2017) Percentages of CB 1 receptor immunopositive astrocytic processes in CB 1 -WT (42.06% 6 3.56%) and GFAP-CB 1 -RS (37.12% 6 3.79%) do not show statistical differences. The proportion of 59.91% 6 3.29% in GFAPhrGFP-CB 1 -WT is statistically significant. Only residual background is found in STOP-CB 1 (1.46% 6 .78%), GFAP-CB 1 -KO (1.45% 6 .77%), CB 1 -KO (.54% 6 .39%) and GFAPhrGFP-CB 1 -KO (1.16% 6 .67%). The number of astrocytic processes examined is in parentheses on the top of each column. (b). CB 1 receptor immunoparticle density on membranes of astrocytic processes (particles/mm). Densities in CB 1 -WT (.135 6 .019) and GFAP-CB 1 -RS (.128 6 .020) are statistically similar, whereas a significant increase in particle density is found in GFAPhrGFP-CB 1 -WT (.384 6 .039). Non-specific particles are detected in STOP-CB 1 (.005 6 .003), GFAP-CB 1 -KO (.005 6 .003), CB 1 -KO (.001 6 .001) and GFAPhrGFP-CB 1 -KO (.004 6 .002). (c) Proportion of CB 1 receptor gold particles on astrocytic membranes versus total CB 1 receptor expression on plasmalemma: 5.31% 6 .84% of the total CB 1 receptor immunoparticles are located in astrocytes of CB 1 -WT and 95.31% 6 1.87% in astrocytes of GFAP-CB 1 -RS. Only residual CB 1 immunoparticles are in astrocytic processes of STOP-CB 1 (1.76% 6 1.29%), GFAP-CB 1 -KO (1.96% 6 1.28%), CB 1 -KO (1.02% 6 .72%) and GFAPhrGFP-CB 1 -KO (1.62% 6 .94%). (d) Proportion of immunogold particles on synaptic terminals versus total CB 1 receptor expression on plasmalemma: 65.52% 6 2.44% (CB 1 -WT), 75.13% 6 4.06% (GFAP-CB 1 -KO), and 56.32% 6 2.73% (GFAPhrGFP-CB 1 -WT). Residual CB 1 receptor immunoparticles are in astrocytes of GFAP-CB 1 -RS (2.02% 6 1.17%), STOP-CB 1 (1.47% 6 .84%), CB 1 -KO (1.52% 6 .87%) and GFAPhrGFP-CB 1 -KO (2.08% 6 1.19%). Data are expressed as mean 6 SEM of three different animals. Data were analyzed by means of Kruskal-Wallis Test and the Dunn's Multiple Comparison Post-hoc test. ***p < .001; **p < .01; *p < .05. As: astrocytic processes; ter: terminal; part: immunoparticles immunostaining, a cytoskeletal protein assembled in intermediate filament packets (Hol & Pekny, 2015) , is mostly restricted to the main branches of the astrocyte. However, hrGFP is a diffusible protein extending into the delicate astrocytic processes that normally lack GFAP (Nolte et al., 2001) , accomplishing better detection of the astrocyte processes. Finally, maybe there epigenetic mechanisms leading to the difference between GFAPhrGFP-CB 1 -WT and GFAP-CB 1 -RS, as in rescue mice re-expression was induced in the adult. and astrocytes through rising calcium in astrocytes that modulates synaptic transmission and plasticity (Araque, Castillo, Manzoni, & Tonini, 2017; G omez-Gonzalo et al., 2015; Martin-Fernandez et al., 2017; Navarrete & Araque, 2008 , 2010 Navarrete et al., 2013; Navarrete, Diez, & Araque, 2014) . Astroglial CB 1 receptor activation regulates astrocytic D-aspartate uptake (Shivachar, 2007) and might contribute to the brains energy supply through the control of leptin receptors expression in astrocytes (Bosier et al., 2013) . Furthermore, CB 1 receptor expression increases in astrocytes of the sclerotic hippocampus (Meng et al., 2014) and blockade of the astroglial CB 1 receptors modulates the intracellular calcium signaling dampening epileptiform activity (Coiret et al., 2012) . In addition, a strong decrease in CB 1 receptors in FIG URE 6 Statistical assessment of the CB 1 receptor distribution on astrocytes in the dentate molecular layer of the mutant mice. (a). Similar percentages of CB 1 receptor immunopositive astrocytic processes in CB 1 -WT (44.67% 6 3.85%) and GFAP-CB 1 -RS (39.84% 6 3.50%) are found. Statistical differences are obtained in GFAPhrGFP-CB 1 -WT (59.99% 6 3.37%). Just residual particles are in: STOP-CB 1 (1.33% 6 .64%), GFAP-CB 1 -KO (1.59% 6 .66%), CB 1 -KO (1.19% 6 .71%) and GFAPhrGFP-CB 1 -KO (.47% 6 .36%). The number of astrocytic processes studied is in parentheses on the top of each column. (b) Analysis of CB 1 receptor density (particles/mm) on astrocytic processes shows no statistical differences between CB 1 -WT (.112 6 .011) and GFAP-CB 1 -RS (.138 6 .016); however, the density on GFAPhrGFP-CB 1 -WT (.334 6 .033) is statistically higher. Only residual background is counted in STOP-CB 1 (.006 6 .003), GFAP-CB 1 -KO (.006 6 .003), CB 1 -KO (.004 6 .002) and GFAPhrGFP-CB 1 -KO (.002 6 .002). (c) Proportion of CB 1 receptor immunoparticles on astrocytic membranes versus total CB 1 receptor expression on plasmalemma: 5.35% 6 1.00% (CB 1 -WT), 95.61% 6 1.56% (GFAP-CB 1 -RS). Almost null non-specific immunoparticles are found in STOP-CB 1 (1.65% 6 .66%), GFAP-CB 1 -KO (1.45% 6 1.45%), CB 1 -KO (1.43% 6 1.43%) and GFAPhrGFP-CB 1 -KO (1.37% 6 1.37%).
(d) Proportion of immunogold particles localized on synaptic terminals versus total CB 1 receptor expression on plasmalemma: 64.27% 6 2.88% (CB 1 -WT), 76.17% 6 4.70% (GFAP-CB 1 -KO), 57.17% 6 2.19% (GFAPhrGFP-CB 1 -WT). Only background levels are in synaptic terminals of GFAP-CB 1 -RS (2.19% 6 1.10%), STOP-CB 1 (2.36% 6 .85%), CB 1 -KO (2.14% 6 1.22%) and GFAPhrGFP-CB 1 -KO (2.06% 6 1.52%). Data are expressed as mean 6 SEM of three different animals. Data were analyzed by means of Kruskal-Wallis test and the Dunn's multiple comparison post-hoc test. ***p < .001; **p < .01; *p < .05. As: astrocytic processes; ter: terminal; part: immunoparticles adult mouse CA1 astrocytes has been recently observed after adolescent drinking-in-the-dark ethanol intake patterns (Bonilla-Del Río et al., 2017) . Taken together, the subcellular compartmentalization of the CB 1 receptor in astrocytes suggests the existence of specific and precise distribution of the receptor that seems to be crucial for the functional role of the CB 1 receptor at the tripartite synapse Araque, Castillo, Manzoni, & Tonini, 2017; Belluomo et al., 2015; Han et al., 2012; Metna-Laurent & Marsicano, 2015; Navarrete & Araque, 2008 , 2010 Oliveira da Cruz et al., 2015; Perez-Alvarez et al., 2014) .
| CB 1 receptors in astroglial mitochondria and potential functional implications
We estimated that 10%-15% of the total CB 1 receptor labeling in the hippocampus is localized at mitochondrial membranes (B enard et al., 2012; Bonilla-Del Río et al., 2017; Hebert-Chatelain et al., 2016) , and this percentage is increased in muscle and heart (Mendizabal-Zubiaga et al., 2016) . Yet, about 22% of the mitochondrial sections in axon terminals and somatodendritic domains contain CB 1 receptors (HebertChatelain et al., 2014a,b) . In the present study, 11%-13% of the astrocytic mitochondrial sections were CB 1 receptor immunopositive, FIG URE 7 Proportion of CB 1 receptor immunopositive astrocytic mitochondria in the CA1 and dentate molecular layer of wild-type and mutant mice. (a) Values of the CB 1 receptor immunopositive astrocytic mitochondria in GFAP-CB 1 -RS (12.39% 6 1.81%) and GFAPhrGFP-CB 1 -WT (13.12% 6 2.53%) are closely similar to CB 1 -WT (11.12% 6 1.79%) in the CA1 stratum radiatum. The background in astroglial mitochondria is: STOP-CB 1 (4.66% 6 1.55%), GFAP-CB 1 -KO (3.97% 6 1.71%), CB 1 -KO (2.97% 6 1.15%) and GFAPhrGFP-CB 1 -KO (.95% 6 .95%).
The number of total mitochondria examined is in parentheses on the top of each column. (b) In the dentate molecular layer, the values of CB 1 receptor immunopositive astrocytic mitochondria in GFAP-CB 1 -RS (11.48% 6 1.76%) and GFAPhrGFP-CB 1 -WT (13.74% 6 3.20%) are comparable to the CB 1 -WT (11.56% 6 2.33%). Background in astroglial mitochondria is: STOP-CB 1 (5.38% 6 1.22%), GFAP-CB 1 -KO (3.05% 6 1.04%), CB 1 -KO (2.49% 6 .80%), GFAPhrGFP-CB 1 -KO (1.98% 6 .91%). The number of total mitochondria examined is in parentheses on the top of each column. Data are expressed as mean 6 SEM of three different animals. Data were analyzed by means of Kruskal-Wallis test and the Dunn's multiple comparison post-hoc test. ***p < .001; **p < .01; *p < .05. As: astrocytic processes; mito: mitochondria
Distance from the mitochondrial CB 1 receptor particles in astrocytes to the synapses in the hippocampus. The distance between the CB 1 receptor particles on mitocondrial membranes in astrocytic processes and the midpoint of the nearest synapse surrounded by them was assessed in the CA1 (a) and dentate molecular layer (b) of CB 1 -WT, GFAP-CB 1 -RS and GFAPhrGFP-CB 1 -WT (see Table 1 for values)
indicating that mtCB 1 receptors in astrocytes might play important functional roles. Indeed, their activation may impact functions in which astroglial CB 1 receptors are involved, such as metabolic activity, neuroprotection, inflammatory responses, astrocyte development and survival, synaptic transmission, plasticity or memory formation (Aguado et al., 2006; Araque et al., 2014; Araque, Castillo, Manzoni, & Tonini, 2017; Bosier et al., 2013; Han et al., 2012; Metna-Laurent & Marsicano, 2015; Navarrete & Araque, 2008 , 2010 Stella, 2010) . (Han et al., 2012) . The GFAP-CB 1 -RS mouse expressing CB 1 receptors exclusively in astrocytes described here, together with the Glu-CB 1 -RS rescue mouse expressing the receptor only in dorsal telencephalic glutamatergic neurons (de Salas-Quiroga et al., 2015; Lange et al., 2017; Ruehle et al., 2013; Soria-G omez et al., 2014) and the GABA-CB 1 -RS rescue mouse expressing the CB 1 receptor only in GABAergic neurons (de Salas-Quiroga et al., 2015; Lange et al., 2017) that were recently characterized anatomically (Guti errez-Rodríguez Remmers et al., 2017) , suggest that the regulation of the 
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